IDXX (STOCKS)
Idexx Laboratories Inc
$566.930000
-3.650000 (-0.64%)
Prev close: $570.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael Erickson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $44,878.10M
- Employees
- 11,000
- P/E (TTM)
- 40.10
- P/B (TTM)
- 27.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
7
Buy
8
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$4.27 | $4.02 | +0.2495 | +6.21% |
|
Mar 2026 (Q1)
|
$3.47 | $3.47 | +0.0033 | +0.10% |
|
Dec 2025 (Q4)
|
$3.08 | $2.99 | +0.0931 | +3.12% |
|
Sep 2025 (Q3)
|
$3.40 | $3.19 | +0.2065 | +6.47% |
Financial Statements
| Revenues | $4.55B |
| Benefits Costs and Expenses | $3.13B |
| Cost Of Revenue | $1.71B |
| Costs And Expenses | $3.13B |
| Gross Profit | $2.84B |
| Operating Expenses | $1.38B |
| Research and Development | $261.47M |
| Other Operating Expenses | $1.12B |
| Operating Income/Loss | $1.46B |
| Income/Loss From Continuing Operations After Tax | $1.14B |
| Income/Loss From Continuing Operations Before Tax | $1.42B |
| Income Tax Expense/Benefit | $284.76M |
| Net Income/Loss | $1.14B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.14B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.14B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $10.34M |
| Basic Earnings Per Share | $14.32 |
| Diluted Earnings Per Share | $14.23 |
| Basic Average Shares | 159,217,000 |
| Diluted Average Shares | 160,235,000 |
| Assets | $3.44B |
| Current Assets | $1.51B |
| Inventory | $391.58M |
| Prepaid Expenses | $61.96M |
| Other Current Assets | $1.06B |
| Noncurrent Assets | $1.93B |
| Fixed Assets | $733.24M |
| Intangible Assets | $98.17M |
| Other Non-current Assets | $1.10B |
| Liabilities | $1.83B |
| Current Liabilities | $1.29B |
| Accounts Payable | $129.10M |
| Wages | $158.13M |
| Other Current Liabilities | $1.00B |
| Noncurrent Liabilities | $542.10M |
| Equity | $1.61B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.61B |
| Liabilities And Equity | $3.44B |
| Net Cash Flow From Operating Activities | $1.37B |
| Net Cash Flow From Operating Activities, Continuing | $1.37B |
| Net Cash Flow From Investing Activities | -$132.04M |
| Net Cash Flow From Investing Activities, Continuing | -$132.04M |
| Net Cash Flow From Financing Activities | -$1.21B |
| Net Cash Flow From Financing Activities, Continuing | -$1.21B |
| Exchange Gains/Losses | -$1.50M |
| Net Cash Flow | $32.34M |
| Net Cash Flow, Continuing | $33.84M |
| Comprehensive Income/Loss | $1.15B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.15B |
| Other Comprehensive Income/Loss | -$523.25M |
| Other Comprehensive Income/Loss Attributable To Parent | $13.41M |